Monoclonal antibodies in targeted therapy
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2012, Vol 66, Issue 0
Abstract
Targeted therapy is a new therapeutic method consisting in the inhibition of specific molecular pathways. In modern therapy, the key role is played by monoclonal antibodies, included in the group of biological agents. The success of molecularly targeted therapy is to define the proper “molecular target”, selecting the right drug active against a specific “target” and selecting a group of patients who benefit from treatment. Introduction of targeted therapy resulted in improved results of the treatment of many serious and chronic diseases. In general, targeted molecular therapies have good toxicity profiles, but some patients are exquisitely sensitive to these drugs and can develop particular and severe toxicities. Patient selection and proper monitoring significantly decrease the risk of life-threatening adverse events. Data concerning late side effects are still unavailable because of the short follow-up of molecularly targeted therapy. Currently in the U.S. and Europe there are approximately 31 registered therapeutic monoclonal antibodies, while 160 are subjected to clinical trials. This paper presents an overview of therapeutic monoclonal antibodies currently used in therapy and the present state of knowledge about them.
Authors and Affiliations
Beata Powroźnik, Paulina Kubowicz, Elżbieta Pękala
Keywords
Related Articles
- EP ID EP66771
- DOI -
- Views 151
- Downloads 0
The role of extracellular vesicles in parasite-host interaction
Extracellular vesicles (EVs), initially considered cell debris, were soon proved to be an essential tool of intercellular communication enabling the exchange of information without direct contact of the cells. At present...
Bacterial type I topoisomerases – biological function and potential use as targets for antibiotic treatments
The bacterial chromosome is composed of topologically independent domains, whose spatial organization is controlled by enzymes called topoisomerases. Topology maintenance is crucial in many important cellular processes s...
Menopauza, otyłość a stan kośćca
Dotychczasowe badania wskazują, że otyłość nie jest czynnikiem ryzyka osteoporozy. Zwiększenie masy tłuszczu ustrojowego, może mieć znaczenie zapobiegawcze przed utratą masy kostnej po menopauzie. Przyjmuje się, że korzy...
Insulin resistance and chronic inflammation
Insulin resistance is a condition of reduced biological response to insulin. Growing evidence indicates the role of the chronic low-grade inflammatory response in the pathogenesis of insulin resistance. Adipose tissue in...
Carbon monoxide in human physiology – its role in the gastrointestinal tract
Carbon monoxide (CO) is produced endogenously in the body as a byproduct of heme degradation catalyzed by the action of heme oxygenase (HO) enzymes. An inducible form, HO-1, responds to many factors such as oxidative str...